已发表论文

miR-124 是结直肠癌的一个潜在治疗靶点

 

Authors Qin Z, Liu X

Received 8 July 2018

Accepted for publication 19 September 2018

Published 22 January 2019 Volume 2019:12 Pages 749—751

DOI https://doi.org/10.2147/OTT.S179501

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Andrew Yee

Peer reviewer comments 2

Editor who approved publication: Dr Samir Farghaly

Abstract: Recently, miR-124 has been regarded as a critical modulator of colorectal cancer. We here summarize the studies on the role and mechanism of miR-124 in colorectal cancer. They indicate that miR-124 is methylated during carcinogenesis and functions as a tumor-suppressor in colorectal cancer. miR-124 might serve as a potential diagnostic biomarker and therapeutic target in colorectal cancer in the foreseeable future.
Keywords: miR-124, colorectal cancer, biomarker, methylation, therapeutic target




Figure 1 miR-124 in colorectal cancer.